These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7001722)

  • 21. The recovery of Bordetella bronchiseptica strains by means of smears from the nasal cavities of pigs.
    Handl R
    Comp Immunol Microbiol Infect Dis; 1979; 2(4):555-8. PubMed ID: 398246
    [No Abstract]   [Full Text] [Related]  

  • 22. Nasal turbinate atrophy in young mice inoculated with Bordetella bronchiseptica of pig origin.
    Sawata A; Kume K
    Am J Vet Res; 1982 Oct; 43(10):1845-7. PubMed ID: 7149389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bordetella bronchiseptica infection.
    Ducours M; Rispal P; Danjean MP; Imbert Y; Dupont E; Traissac EM; Grosleron S
    Med Mal Infect; 2017 Nov; 47(7):453-458. PubMed ID: 28943167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental atrophic rhinitis produced by Bordetella bronchiseptica culture in young pigs.
    Kemeny LJ
    Cornell Vet; 1972 Jul; 62(3):477-85. PubMed ID: 5039612
    [No Abstract]   [Full Text] [Related]  

  • 25. Nasal and tracheal resistance of swine against reinfection by Bordetella bronchiseptica.
    Harris DL; Switzer WP
    Am J Vet Res; 1969 Jul; 30(7):1161-6. PubMed ID: 4978600
    [No Abstract]   [Full Text] [Related]  

  • 26. Properties of an R factor from Bordetella bronchiseptica.
    Hedges RW; Jacob AE; Smith JT
    J Gen Microbiol; 1974 Sep; 84(1):199-204. PubMed ID: 4612099
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antibiotic sensitivity of Hungarian Bordatella bronchiseptica strains].
    Füzi M
    Orv Hetil; 1972 Dec; 113(53):3185-7. PubMed ID: 4639607
    [No Abstract]   [Full Text] [Related]  

  • 28. Interaction between immunity to Bordetella bronchiseptica and infection of pig herds by Bordetella bronchiseptica and Pasteurella multocida.
    Eliás B; Krüger M; Gergely P; Voets R; Rafai P
    J Vet Med Sci; 1993 Aug; 55(4):617-22. PubMed ID: 8399743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental Bordetella bronchiseptica infection in embryonated eggs.
    Shirk RJ; Kemp GA
    Antimicrob Agents Chemother (Bethesda); 1967; 7():178-82. PubMed ID: 5596139
    [No Abstract]   [Full Text] [Related]  

  • 30. Serum sensitivity and lipopolysaccharide characteristics in Bordetella bronchiseptica, B. pertussis and B. parapertussis.
    Byrd DW; Roop RM; Veit HP; Schurig GG
    J Med Microbiol; 1991 Mar; 34(3):159-65. PubMed ID: 2010907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Problems associated with the identification of bordetella bronchiseptica.
    Simpson W; Simmons DJ
    Lab Anim; 1976 Jan; 10(1):47-8. PubMed ID: 1256014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Influence of restrictive use of antibiotics on the development of drug resistance in intestinal Escherichia coli from pigs (author's transl)].
    Larsen JL; Nielsen NC
    Nord Vet Med; 1975; 27(7-8):353-64. PubMed ID: 1099531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacteriological variation among Bordetella bronchiseptica isolates from dogs and other species.
    Bemis DA; Greisen HA; Appel MJ
    J Clin Microbiol; 1977 Apr; 5(4):471-80. PubMed ID: 858784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity of killed Bordetella bronchiseptica vaccines in the mouse.
    Smith IM; Baskerville AJ; Brothwell E; Oliphant J
    Res Vet Sci; 1982 Mar; 32(2):248-52. PubMed ID: 7079606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decrease in antimicrobial susceptibility of Bordetella bronchiseptica caused by antigenic modulation and phase variation.
    Ishikawa H; Isayama Y; Ohmae K
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1891-2. PubMed ID: 3245700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the inhibitory effect of sulfamonomethoxine and other sulfonamides on capsule formation of Bordetella bronchiseptica.
    Kuwano A; Ito T; Tachi H; Hiramune T
    J Vet Med Sci; 1992 Oct; 54(5):1057-9. PubMed ID: 1420559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro antimicrobial activity of sulfonamides against some porcine pathogens.
    Mengelers MJ; van Klingeren B; van Miert AS
    Am J Vet Res; 1989 Jul; 50(7):1022-8. PubMed ID: 2774319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virulence of Bordetella bronchiseptica in the porcine respiratory tract.
    Collings LA; Rutter JM
    J Med Microbiol; 1985 Apr; 19(2):247-55. PubMed ID: 2858594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of various oral dose levels of a trimethoprim/sulphadiazine mixture on Bordetella bronchiseptica infection and on the proliferation of trimethoprim-resistant faecal coliforms in pigs.
    Dassanayake L; White G
    J Hyg (Lond); 1983 Feb; 90(1):41-7. PubMed ID: 6822727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bordetella bronchiseptica isolations from the nasal cavity of pigs in relation to atrophic rhinitis.
    Tornoe N; Nielsen NC; Svendsen J
    Nord Vet Med; 1976 Jan; 28(1):1-18. PubMed ID: 1250685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.